Givaudan | GIVN - Current Liabilities


Givaudan reported CHF2.35B in Current Liabilities for its fiscal semester ending in December of 2025.





Current Liabilities Change Date
Air Liquide EUR 11.46B 2.7B Jun/2026
Akzo Nobel EUR 4.31B 77M Jun/2026
Anheuser-Busch USD 33.48B 999M Jun/2026
Arkema EUR 3.16B 1.01B Jun/2026
Associated British Foods GBP 4.04B 321M Dec/2025
BASF EUR 20.91B 1.26B Jun/2026
Bayer EUR 33.46B 875M Mar/2026
Beiersdorf EUR 3.51B 261M Dec/2025
British American Tobacco GBP 14.28B 246M Jun/2026
Covestro EUR 3.87B 299M Dec/2025
Croda International GBP 547.7M 209.7M Dec/2024
Danone EUR 16.6B 1.97B Jun/2026
Diageo GBP 11.78B 1.06B Dec/2025
Fresenius EUR 8.38B 1.18B Dec/2025
Fresenius Medical Care EUR 6.73B 484.42M Mar/2026
Givaudan CHF 2.35B 422M Dec/2025
Heineken EUR 13.93B 932M Dec/2025
Henkel EUR 8.42B 122M Dec/2025
International Flavors Fragrances USD 3.64B 288M Mar/2026
Johnson Matthey GBP 2.53B 211M Jun/2026
Kerry EUR 1.73B 75.7M Jun/2026
Lonza CHF 3.57B 421M Dec/2025
L'Oréal EUR 18.55B 3.18B Jun/2026
Merck EUR 9.35B 307M Mar/2026
Nestle CHF 45.29B 4.6B Jun/2026
Pernod Ricard EUR 5.6B 846M Dec/2025
Reckitt Benckiser GBP 7.94B 901M Dec/2024
SGS CHF 2.53B 53M Dec/2024
Sika AG CHF 3.53B 730M Dec/2025
Solvay EUR 1.78B 6M Jun/2026
Tate & Lyle GBP 493M 82M Jun/2026
Umicore EUR 4.55B 293.7M Jun/2026
Victrex GBP 80.5M 18.9M Jun/2026